NDC 63323-482-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-482
- Requested NDC
- 63323-482-01
- Package NDCs from labels
- 63323-482-41, 63323-482-26, 63323-482-01, 63323-482-17, 63323-482-03, 63323-482-27, 63323-482-05, 63323-482-57
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Sportpharm LLC | Sportpharm LLC | 2026-03-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine 1% (Lidocaine HCL and Epinephrine 1:100,000) USP | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - ProPharma Distribution | ProPharma Distribution | 2025-07-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Leep RediKit | CooperSurgical, Inc. | 2023-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HCl AND EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Cardinal Health | Cardinal Health | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| QKit | CooperSurgical, Inc. | 2016-08-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-482-01 | Xylocaine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-482-03 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-482-05 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-482-17 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-482-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-482-01 | ML - Milliliter | 63323-482 | c7c960aa-c042-4c76-8985-abfc7ddffd35 | 1 | 2019-11-12 |
| 63323-482-03 | ML - Milliliter | 63323-482 | 683318c9-c032-429d-b0a6-5acf426a0cff | 1 | 2019-11-12 |
| 63323-482-05 | ML - Milliliter | 63323-482 | 8e4a4ff6-bc30-4291-b650-70cbca55a0ea | 1 | 2019-11-12 |
| 63323-482-10 | ML - Milliliter | 63323-482 | eeb605c4-0d24-4bcc-812b-c9af4171f021 | 1 | 2013-02-11 |
| 63323-482-17 | ML - Milliliter | 63323-482 | 174b5879-d07f-4342-8e60-68c6453f1219 | 1 | 2012-07-24 |
| 63323-482-26 | ML - Milliliter | 63323-482 | e06d4a2e-b1ab-406d-9e85-1d9d66f47f9e | 1 | 2016-06-14 |
| 63323-482-27 | ML - Milliliter | 63323-482 | 8b11b61e-7a9a-4afd-9877-cf93a6041364 | 1 | 2012-07-24 |
| 63323-482-57 | ML - Milliliter | 63323-482 | 0efa69ac-a284-4b6c-86e8-d723284f92e2 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| BM BM165 DROPS | ANGELICA ATRO, BALSAM PER, BARIUM MUR, GRINDELIA, KALI BICH, KALI IOD, KALI MUR, SILPHIUM LAC | BM Private Limited | 590301da-8f93-3b1e-e063-6394a90a1e72 | 2026-08-14 | Warnings | 1C4QK22F9J |
| BM BM173 DROPS | ECHINACEA, EUPHRASIA, NATRUM MUR, RHUS TOX, SILICEA, SULPHUR, URTICA UREN | BM Private Limited | 59036ca4-e7bb-bbe7-e063-6394a90a410a | 2026-08-14 | Warnings | 451W47IQ8X |
| Refresh AntiBac FOAM | BENZALKONIUM CHLORIDE | SC Johnson Professional USA Inc. | 884d1c8c-5643-423e-8ed4-d2ef38f8af73 | 2026-08-13 | Warnings | F5UM2KM3W7 |
| Natural Lift Lack of energy - Fatigue | AVENA SATIVA 9C, GELSEMIUM SEMPERVIRENS 9C, PANAX GINSENG 3C, NATRUM MURIATICUM 9C | SEVENE USA | 551194c4-dfd8-c42d-e063-6294a90aecee | 2026-08-13 | Warnings | 451W47IQ8X |
| BM BM37 DROPS | BARYTA CARB, BROMIUM, CALC. IOD, CONIUM MAC., IODIUM, SPONGIA TOST | BM Private Limited | 58edd680-09b5-8a43-e063-6294a90a252d | 2026-08-13 | Warnings | 9679TC07X4 |
| BM BM59 DROPS | CALC CARB, DULCAMARA, HEPAR SULPH, LYCOPODIUM, NAT MUR, SULPHUR, THUJA OCC | BM Private Limited | 58ef0755-c2cd-b7c2-e063-6294a90a2707 | 2026-08-13 | Warnings | 451W47IQ8X |
| JJ Care First Aid Burn | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Nantong Health & Beyond Hygienic Products Inc. | c41621fb-c549-4394-a4cb-cb81ef8c98df | 2026-08-13 | Warnings | F5UM2KM3W7 V13007Z41A |
| Xylocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Dentsply Pharmaceutical | 14b55cf9-f7cd-4bb4-a7c5-aba61abadef1 | 2026-08-13 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| CVS Pain Relief Roll-On Lidocaine with Lavender | LIDOCAINE HYDROCHLORIDE | CVS Pharmacy | 4aa53176-2103-b47b-e063-6394a90ac735 | 2026-08-12 | Warnings | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sentiss Pharmaceuticals LLC | 9b2d4f69-0c84-4956-b5c0-b4410acf62e0 | 2026-08-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Septodont, Inc. | 864e511b-cc50-4ed9-b122-8e1a93457332 | 2026-08-11 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| Arterioforce II | BAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), MYRRHA, NASTURTIUM AQUATICUM, PHYTOLACCA DECANDRA, TRIGONELLA FOENUM-GRAECUM, HYDRASTIS CANADENSIS, KALI IODATUM, ARNICA MONTANA, CACTUS GRANDIFLORUS, PROPOLIS, BARYTA CARBONICA, CONIUM MACULATUM, SECALE CORNUTUM | BioActive Nutritional, Inc. | ef98fbda-6815-4d0d-b07e-62ce420c4dee | 2026-08-11 | Warnings | 1C4QK22F9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.